Global Cell Therapy Market Research Report 2021
Global Cell Therapy Market Research Report 2021
Discover the latest insights into the booming Cell Therapy Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Cell Therapy Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Cell Therapy Market Overview:
Global Cell Therapy Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Cell Therapy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Cell Therapy Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Cell Therapy market in 2020.
Global Cell Therapy Market Segmentation
By Type, Cell Therapy market has been segmented into:
Nanotechnology
Natural Substances
By Application, Cell Therapy market has been segmented into:
Scientific Research
Hospital
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Cell Therapy market are:
Dendreon
Mesoblast
Vericel
AlloCure
Amorcyte
Anterogen
Antibe Therapeutics
Astellas Pharma
Athersys
Avita Medical
AxoGen
Bellicum Pharmaceuticals
BioCardia
BIOCELLULAR THERAPIES
Biogen Idec
Bio-Tissue
BIOTIME
BioTissue Technologies
BrainStorm Cell Therapeutics
Bluebird Bio
Bone Therapeutics
Caladrius
Capricor Therapeutics
CellBioMed
Celgene
Cell Medica
1. Market Overview of Cell Therapy
1.1 Cell Therapy Market Overview
1.1.1 Cell Therapy Product Scope
1.1.2 Market Status and Outlook
1.2 Cell Therapy Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Cell Therapy Historic Market Size by Regions (2015-2020)
1.4 Cell Therapy Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Cell Therapy Sales Market by Type (2015-2026)
2.1 Global Cell Therapy Historic Market Size by Type (2015-2020)
2.2 Global Cell Therapy Forecasted Market Size by Type (2021-2026)
2.3 Nanotechnology
2.4 Natural Substances
3. Covid-19 Impact Cell Therapy Sales Market by Application (2015-2026)
3.1 Global Cell Therapy Historic Market Size by Application (2015-2020)
3.2 Global Cell Therapy Forecasted Market Size by Application (2021-2026)
3.3 Scientific Research
3.4 Hospital
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Cell Therapy Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Cell Therapy Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Cell Therapy Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Cell Therapy Business
5.1 Dendreon
5.1.1 Dendreon Company Profile
5.1.2 Dendreon Cell Therapy Product Specification
5.1.3 Dendreon Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Mesoblast
5.2.1 Mesoblast Company Profile
5.2.2 Mesoblast Cell Therapy Product Specification
5.2.3 Mesoblast Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Vericel
5.3.1 Vericel Company Profile
5.3.2 Vericel Cell Therapy Product Specification
5.3.3 Vericel Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 AlloCure
5.4.1 AlloCure Company Profile
5.4.2 AlloCure Cell Therapy Product Specification
5.4.3 AlloCure Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Amorcyte
5.5.1 Amorcyte Company Profile
5.5.2 Amorcyte Cell Therapy Product Specification
5.5.3 Amorcyte Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Anterogen
5.6.1 Anterogen Company Profile
5.6.2 Anterogen Cell Therapy Product Specification
5.6.3 Anterogen Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Antibe Therapeutics
5.7.1 Antibe Therapeutics Company Profile
5.7.2 Antibe Therapeutics Cell Therapy Product Specification
5.7.3 Antibe Therapeutics Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Astellas Pharma
5.8.1 Astellas Pharma Company Profile
5.8.2 Astellas Pharma Cell Therapy Product Specification
5.8.3 Astellas Pharma Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Athersys
5.9.1 Athersys Company Profile
5.9.2 Athersys Cell Therapy Product Specification
5.9.3 Athersys Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Avita Medical
5.10.1 Avita Medical Company Profile
5.10.2 Avita Medical Cell Therapy Product Specification
5.10.3 Avita Medical Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 AxoGen
5.11.1 AxoGen Company Profile
5.11.2 AxoGen Cell Therapy Product Specification
5.11.3 AxoGen Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Bellicum Pharmaceuticals
5.12.1 Bellicum Pharmaceuticals Company Profile
5.12.2 Bellicum Pharmaceuticals Cell Therapy Product Specification
5.12.3 Bellicum Pharmaceuticals Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 BioCardia
5.13.1 BioCardia Company Profile
5.13.2 BioCardia Cell Therapy Product Specification
5.13.3 BioCardia Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 BIOCELLULAR THERAPIES
5.14.1 BIOCELLULAR THERAPIES Company Profile
5.14.2 BIOCELLULAR THERAPIES Cell Therapy Product Specification
5.14.3 BIOCELLULAR THERAPIES Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Biogen Idec
5.15.1 Biogen Idec Company Profile
5.15.2 Biogen Idec Cell Therapy Product Specification
5.15.3 Biogen Idec Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Bio-Tissue
5.16.1 Bio-Tissue Company Profile
5.16.2 Bio-Tissue Cell Therapy Product Specification
5.16.3 Bio-Tissue Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 BIOTIME
5.17.1 BIOTIME Company Profile
5.17.2 BIOTIME Cell Therapy Product Specification
5.17.3 BIOTIME Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 BioTissue Technologies
5.18.1 BioTissue Technologies Company Profile
5.18.2 BioTissue Technologies Cell Therapy Product Specification
5.18.3 BioTissue Technologies Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.19 BrainStorm Cell Therapeutics
5.19.1 BrainStorm Cell Therapeutics Company Profile
5.19.2 BrainStorm Cell Therapeutics Cell Therapy Product Specification
5.19.3 BrainStorm Cell Therapeutics Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.20 Bluebird Bio
5.20.1 Bluebird Bio Company Profile
5.20.2 Bluebird Bio Cell Therapy Product Specification
5.20.3 Bluebird Bio Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.21 Bone Therapeutics
5.21.1 Bone Therapeutics Company Profile
5.21.2 Bone Therapeutics Cell Therapy Product Specification
5.21.3 Bone Therapeutics Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.22 Caladrius
5.22.1 Caladrius Company Profile
5.22.2 Caladrius Cell Therapy Product Specification
5.22.3 Caladrius Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.23 Capricor Therapeutics
5.23.1 Capricor Therapeutics Company Profile
5.23.2 Capricor Therapeutics Cell Therapy Product Specification
5.23.3 Capricor Therapeutics Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.24 CellBioMed
5.24.1 CellBioMed Company Profile
5.24.2 CellBioMed Cell Therapy Product Specification
5.24.3 CellBioMed Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.25 Celgene
5.25.1 Celgene Company Profile
5.25.2 Celgene Cell Therapy Product Specification
5.25.3 Celgene Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.26 Cell Medica
5.26.1 Cell Medica Company Profile
5.26.2 Cell Medica Cell Therapy Product Specification
5.26.3 Cell Medica Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Cell Therapy Market Size (2015-2026)
6.2 North America Cell Therapy Key Players in North America (2015-2020)
6.3 North America Cell Therapy Market Size by Type (2015-2020)
6.4 North America Cell Therapy Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Cell Therapy Market Size (2015-2026)
7.2 East Asia Cell Therapy Key Players in North America (2015-2020)
7.3 East Asia Cell Therapy Market Size by Type (2015-2020)
7.4 East Asia Cell Therapy Market Size by Application (2015-2020)
8. Europe
8.1 Europe Cell Therapy Market Size (2015-2026)
8.2 Europe Cell Therapy Key Players in North America (2015-2020)
8.3 Europe Cell Therapy Market Size by Type (2015-2020)
8.4 Europe Cell Therapy Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Cell Therapy Market Size (2015-2026)
9.2 South Asia Cell Therapy Key Players in North America (2015-2020)
9.3 South Asia Cell Therapy Market Size by Type (2015-2020)
9.4 South Asia Cell Therapy Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Cell Therapy Market Size (2015-2026)
10.2 Southeast Asia Cell Therapy Key Players in North America (2015-2020)
10.3 Southeast Asia Cell Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Cell Therapy Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Cell Therapy Market Size (2015-2026)
11.2 Middle East Cell Therapy Key Players in North America (2015-2020)
11.3 Middle East Cell Therapy Market Size by Type (2015-2020)
11.4 Middle East Cell Therapy Market Size by Application (2015-2020)
12. Africa
12.1 Africa Cell Therapy Market Size (2015-2026)
12.2 Africa Cell Therapy Key Players in North America (2015-2020)
12.3 Africa Cell Therapy Market Size by Type (2015-2020)
12.4 Africa Cell Therapy Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Cell Therapy Market Size (2015-2026)
13.2 Oceania Cell Therapy Key Players in North America (2015-2020)
13.3 Oceania Cell Therapy Market Size by Type (2015-2020)
13.4 Oceania Cell Therapy Market Size by Application (2015-2020)
14. South America
14.1 South America Cell Therapy Market Size (2015-2026)
14.2 South America Cell Therapy Key Players in North America (2015-2020)
14.3 South America Cell Therapy Market Size by Type (2015-2020)
14.4 South America Cell Therapy Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Cell Therapy Market Size (2015-2026)
15.2 Rest of the World Cell Therapy Key Players in North America (2015-2020)
15.3 Rest of the World Cell Therapy Market Size by Type (2015-2020)
15.4 Rest of the World Cell Therapy Market Size by Application (2015-2020)
16 Cell Therapy Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Cell Therapy Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|